Inventor · disambiguated record
Lawrence Luepschen
Also filed as: LUEPSCHEN LAWRENCE · LUEPSCHEN LAWRENCE K
7 granted patents·5 pending applications·160 citations·filing 1997–2008
87Inventor score
Top patents by PatentIndex Score
12 records- 0192US7824677B2Method for using antibodies for inhibiting blood coagulationGENENTECH INC·Filed 2008·Granted Nov 2, 2010·15 cites·29 claims
- 0291US5986065AAntibodies for inhibiting blood coagulation and methods of use thereofSUNOL MOLECULAR CORP·Filed 1997·Granted Nov 16, 1999·77 cites·5 claims
- 0386US6555319B2Antibodies for inhibiting blood coagulation and methods of use thereofSUNOL MOLECULAR CORP·Filed 1999·Granted Apr 29, 2003·48 cites·40 claims
- 0474US6608066B1Tissue factor antagonists and methods of use thereofSUNOL MOLECULAR CORP·Filed 2000·Granted Aug 19, 2003·8 cites·14 claims
- 0572US6849617B2Tissue factor antagonists and methods of use thereofSUNOL MOLECULAR CORP·Filed 2003·Granted Feb 1, 2005·6 cites·15 claims
- 0664US2005271664A1Antibodies for inhibiting blood coagulation and methods of use thereofTANOX INC·Filed 2005·Application pending·0 cites
- 0761US2006039901A1Antibodies for inhibiting blood coagulation and methods of use thereofTANOX INC·Filed 2005·Application pending·0 cites
- 0857US2007155703A1Pharmaceutically active compounds and methods of use thereofTANOX INC·Filed 2007·Application pending·0 cites
- 0956US2003109680A1Antibodies for inhibiting blood coagulation and methods of use thereofSUNOL MOLECULAR CORP·Filed 2001·Application pending·0 cites
- 1054US2003082636A1Antibodies for inhibiting blood coagulation and methods of use thereofSUNOL MOLECULAR CORP·Filed 2002·Application pending·0 cites
- 1152US7199113B2Pharmaceutically active compounds and methods of use thereofJIAO JIN-AN·Filed 2004·Granted Apr 3, 2007·0 cites·10 claims
- 1249US6828312B2Pharmaceutically active compounds and methods of use thereofSUNOL MOLECULAR CORP·Filed 1999·Granted Dec 7, 2004·6 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Lawrence Luepschen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →